Prosidyan
Manufacturing · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
41 Spring St Ste 107, New Providence, Ne...Phone Number
(908) 517-3666Website
www.prosidyan.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Prosidyan
Prosidyan was founded in 2009 to develop a family of synthetic bioactive bone graft substitutes based on proprietary bioactive glass fibers. Prosidyan's first product, FIBERGRAFT BG Morsels, a synthetic bone graft substitute, received FDA clearance in March 2014, and the first surgery utilizing this innovative bone graft substitute was performed in May 2014. The Company's second product in the line, FIBERGRAFT BG Putty, received FDA clearance in March 2015, and comprises FIBERGRAFT BG Morsels in combination with Prosidyan's proprietary bioactive carrier, OSSIGLIDE®. Prosidyan's latest technology, FIBERGRAFT BG Matrix launched in August 2017, uses Prosidyan's proprietary type I collagen-based bioactive carrier.Explore more
Prosidyan Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Prosidyan your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Prosidyan
Funding: Get notified immidiatlly once Prosidyan has new funding data
Earning: See what the market has to say on Prosidyan recently announced quarterly report
Check if Prosidyan has recently received funding, and reach out quickly before it becomes old news!
Click to see if Prosidyan had a recent Job posting/layoffs
Product Launch: Get notified when Prosidyan launches new products
Prosidyan, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Prosidyan is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Prosidyan
Find 3 more new buyers
Compare Similar Companies to Prosidyan
Compare insights from companies similar to Prosidyan, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Prosidyan is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Prosidyan is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Prosidyan.
Prosidyan financials insights
Gather financial insights about Prosidyan, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
Prosidyan Tech Stack
A closer look at the technologies used by Prosidyan
Prosidyan News & Media
Prosidyan® FIBERGRAFT® Achieves High Fusion Rate in...
FIBERGRAFT® BG Matrix Achieved 96.3% Fusion Rate in Posterolateral Spine Fusion Clinical Study (PRWeb August 26, 2021) Read the full story at https://www.prweb.com/releases/prosidyan_fibergraft_achieves_high_fusion_rate_in_multi_center_clinical_study_presented_at_top_neurosurgery_conference/prweb18152523.htmProsidyan® Receives CE Mark for FIBERGRAFT® BG Family of Products
FIBERGRAFT® BG Putty, FIBERGRAFT® BG Putty GPS, FIBERGRAFT® BG Morsels for use in the Lumbar Spine and Anterior Cervical Spine (PRWeb May 20, 2021) Read the full story at https://www.prweb.com/releases/prosidyan_receives_ce_mark_for_fibergraft_bg_family_of_products/prweb17947815.htm
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Prosidyan
Sign Up For FreeTo access detailed company insights
Prosidyan was founded in 2009 to develop a family of synthetic bioactive bone graft substitutes based on proprietary bioactive glass fibers. Prosidyan's first product, FIBERGRAFT BG Morsels, a synthetic bone graft substitute, received FDA clearance in March 2014, and the first surgery utilizing this innovative bone graft substitute was performed in... Read More
